Leading-edge cancer care by a team of experts from AJH and BIDMC
The team of cancer specialists at Anna Jaques and Beth Israel Deaconess Medical Center is committed to providing to the Anna Jaques community leading-edge cancer care, encompassing a full spectrum of diagnostic and treatment programs. Patients are cared for through a collaboration of experts at both institutions with extensive experience in the diagnosis and treatment of cancer.
Our team of highly trained caregivers includes board certified, highly skilled medical oncologists, radiation oncologists, radiologists, surgeons, pathologists, nurses, therapists, pharmacists, technologists, support staff and other professionals dedicated to treating cancer patients. All our permanent nurses are certified in oncology, and nurses in our chemotherapy infusion room are also certified in oncology. Most of our volunteers are retired nurses, too.
"Tumor Board" Conferences
The Tumor Board brings together a multidisciplinary group of physicians who review individual cancer cases in detail. This ensures that cancer patients have access to the best current thinking about cancer management and latest treatment options available. Oncology specialists from BIDMC join the Cancer Center's bi-weekly Tumor Board conferences via secure teleconferencing technology. They participate in the diagnosis and treatment planning of every patient.
Multidisciplinary Conferences for Breast Cancer Patients
Breast cancer patients participate in a multidisciplinary clinic in which the patient receives care from specialists from many disciplines in one convenient session, in one place.
Physician and Nurse Leadership
Jonathan Eneman, MD
Medical Director of Anna Jaques Cancer Center Affiliated with BIDMC
Dr. Eneman is board certified in internal medicine, hematology and oncology, and will serve as the new medical director of the cancer center. Dr. Eneman received his medical degree from the University of Vermont (UVM), served as an intern and resident at Beth Israel Deaconess Medical Center (BIDMC), and completed his fellowship in Hematology and Medical Oncology at UVM. After completing his fellowship, Dr. Eneman accepted a position with York Hospital in York, Maine where he proudly served as Chairman for the Department of Medicine and helped the oncology program receive the New Program Outstanding Achievement Award from the American College of Surgeons Commission on Cancer. He is inspired daily by both his coworkers and patients.
Colleen Yavarow, DO
Hematology & Oncology
Dr. Colleen Yavarow is board certified in Medical Oncology and Internal Medicine and brings a wealth of experience in a hematology and oncology community practice setting. Dr. Yavarow received her medical education at the University of New England College of Osteopathic Medicine. She trained at Lahey Clinic and St. Elizabeth’s Medical Center where she earned a prestigious fellowship award.
Laura Rossi, RNC, MSN, OCN
Director of Oncology Services at Anna Jaques
Laura Rossi brings 23 years of experience to the role of Director of Oncology Services at AJH. After graduating from nursing school in 1986, she became board certified in Medical Surgery Nursing (RNC), board certified in Oncology Nursing (OCN) and certified in Biotherapy Chemotherapy (ONS). She also earned her Masters of Science in Nursing (MSN) and is certified in Basic Life Support (BLS) and Advanced Cardiac Life Support (ACLS). Laura is an avid problem solver, a passionate patient advocate, and a true leader who empowers her staff to be the best they can be, all while infusing each and every day with laughter.
Nadine Tung, MD
Director, Cancer Genetics and Prevention Program, Cancer Center at BIDMC
Nadine Tung, MD is the director of the Cancer Genetics and Prevention Program at the Cancer Center at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School.
In addition to her clinical work in cancer genetics, Dr. Tung is a breast cancer medical oncologist with expertise in caring for women with breast cancer. She is also active in research in the areas of breast cancer and hereditary susceptibility genes which cause breast and ovarian cancer.
Dr. Tung attended Harvard Medical School and completed her internship, residence and fellowship at Beth Israel Deaconess Medical Center in Boston. She is board certified by the American Board of Internal Medicine in Medical Oncology.
Claire Fung, MD
Radiation Oncologist at Anna Jaques
Dr. Fung is a board-certified radiation oncologist trained at Harvard Medical School and then Massachusetts General Hospital, where she earned a prestigious fellowship award and served on staff for 14 years. Dr. Fung has served as vice president of Commonwealth Hematology Oncology in Quincy, MA. She previously served as medical director at South Suburban Oncology Center in Quincy. Along with producing several original reports, reviews and abstracts, she has taught radiation oncology to medical students at Harvard Medical School and Boston University School of Medicine.
Stuart Berman, MD
Director of Community Radiation Oncology, Cancer Center at BIDMC
Stuart M. Berman, MD, MBA is director of community radiation oncology services for the Cancer Center at Beth Israel Deaconess Medical Center. He is an instructor in radiation oncology at Harvard Medical School. He attended the University of Virginia School of Medicine and completed his residency at the Harvard Joint Center for Radiation Therapy in 1992. He is board certified in radiation oncology by the American Board of Radiology.
Jonathan Arnow, MD
Chief of Radiology at Anna Jaques
Jonathan Arnow, MD, is a board-certified radiologist who specializes in reading breast imaging films, such as mammograms. Dr. Arnow attended medical school at University of Connecticut, did his residency at Tufts New England Medical Center and his fellowship at Brigham and Women's hospital in Boston.
Marc Garnick, MD
Gorman Brothers Professor of Medicine at Harvard Medical School and Director of Community Cancer Services at BIDMC
Renowned for his role in leading-edge research, Marc B. Garnick MD serves as Director of Community Cancer Services for the Cancer Center at Beth Israel Deaconess Medical Center and is the Gorman Professor of Medicine at Harvard Medical School. Garnick received his bachelor degree from Bowdoin College and his medical degree from the University of Pennsylvania School of Medicine, where he also completed his internal medicine internship and residency. He also completed a research and clinical fellowship with the National Institutes of Health and a medical oncology fellowship at the Dana Farber Cancer Institute.
Garnick served as the principal investigator on the development of Lupron, a widely used hormonal therapy for prostate cancer and has also directed the clinical development of several other important cancer therapies. He currently serves on several advisory panels for the federal Food and Drug Administration, advising them on complicated issues related to the safety and efficacy of cancer treatments. He also serves as the editor in chief of the Harvard Medical School’s Annual Report on Prostate Diseases and its associated website, www.harvardprostateknowledge.org
Laurie Harris, MD
Chief of Pathology at Anna Jaques
Dr. Harris is a board-certified pathologist who works with the Aurora Diagnostics Seacoast Medical team based in Exeter, NH. A graduate of Harvard-Radcliffe College, she stayed in Boston to earn her medical degree at Boston University School of Medicine. Her post-graduate training includes a family practice residency at Boston Medical Center and a four-year pathology residency at Beth Israel Deaconess Medical Center, where she went on to complete a fellowship in surgical pathology in 2008, studying several types of cancer
Peter Hartmann, MD, FACS
Medical Director of the Gerrish Breast Care Center at Anna Jaques
Dr. Peter Hartmann is a board-certified general surgeon who brings nearly 25 years of private surgical practice to the role of Medical Director. Since arriving in Newburyport, Dr. Hartmann has been involved with the American College of Surgeons’ Commission on Cancer since 1989. He has had a special interest in breast surgery for decades, and was among the first to use the sentinel node biopsy in New England in the 1990s. Over the years, he has performed approximately 1,000 breast procedures. As a dedicated breast surgeon he focuses exclusively on a variety of breast procedures related to the diagnosis and treatment of breast cancer.